S. Lopresti

Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple

D. Fantl, N. Schütz, P. Ochoa, 2020 .

Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from grupo argentino de mieloma múltiple

D. Fantl, P. Ochoa, P. Duarte, 2021, Expert review of hematology.

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study

M. Roa, C. Sossa, G. Ruiz-Argüelles, 2020, Leukemia & lymphoma.

Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study

L. Villela, J. Castillo, P. Duarte, 2022, JCO global oncology.

Surveillance of growth-retarded fetuses with computerized fetal heart rate monitoring combined with Doppler velocimetry of the umbilical and uterine arteries.

Z. Weiner, H. Schulman, S. Lopresti, 1996, The Journal of reproductive medicine.